Shares Outstanding for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported diluted shares outstanding is 781.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingRevenueSwitch metric
Latest period
781.00M
YoY change
-0.1%
5Y CAGR
+3.5%
Peak year (1999)
888.00M
Latest annual
781.00M
Shares Outstanding history chart for AstraZeneca (AZN) from 1990 to 2025
Shares Outstanding history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 781.00M | -0.1% | ||
| 2024 | 781.50M | +0.1% | ||
| 2023 | 781.00M | +0.1% | ||
| 2022 | 780.00M | +9.3% | ||
| 2021 | 713.50M | +8.7% | ||
| 2020 | 656.50M | +0.9% | ||
| 2019 | 650.50M | +2.7% | ||
| 2018 | 633.50M | 0.0% | ||
| 2017 | 633.50M | +0.1% | ||
| 2016 | 633.00M | +0.1% | ||
| 2015 | 632.50M | +0.1% | ||
| 2014 | 632.00M | +0.8% | ||
| 2013 | 627.00M | -0.8% | ||
| 2012 | 632.00M | -7.5% | ||
| 2011 | 683.50M | -5.5% | ||
| 2010 | 723.00M | -0.3% | ||
| 2009 | 725.00M | -0.2% | ||
| 2008 | 726.50M | -3.0% | ||
| 2007 | 749.00M | -4.6% | ||
| 2006 | 785.00M | -3.0% | ||
| 2005 | 809.00M | -3.3% | ||
| 2004 | 836.50M | -2.1% | ||
| 2003 | 854.50M | -1.5% | ||
| 2002 | 867.50M | -1.3% | ||
| 2001 | 879.00M | -0.6% | ||
| 2000 | 884.00M | -0.5% | ||
| 1999 | 888.00M | +90.2% | ||
| 1998 | 466.80M | -1.8% | ||
| 1997 | 475.50M | +0.4% | ||
| 1996 | 473.50M | +0.1% | ||
| 1995 | 473.00M | 0.0% | ||
| 1994 | 473.00M | +11.3% | ||
| 1993 | 425.00M | +18.6% | ||
| 1992 | 358.30M | 0.0% | ||
| 1991 | 358.30M | 0.0% | ||
| 1990 | 358.30M | — |
Shares Outstanding values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of AstraZeneca (AZN) diluted shares outstanding is 781.00M – edged down 0.1% year-over-year.
Over 2020–2025 (5 years), AstraZeneca diluted shares outstanding expanded at a +3.5% compound annual rate, with the latest reading among the more recent periods of the dataset.
AstraZeneca diluted shares outstanding declined from 888.00M in 1999 to 781.00M in 2025, a 12.0% drawdown.
1999 marks the peak diluted shares outstanding at 888.00M, with the historical low of 358.30M recorded in 1990.
AstraZeneca (AZN) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
AstraZeneca Shares Outstanding by Year
AstraZeneca Shares Outstanding 2025: 781.00M
AstraZeneca diluted shares outstanding in 2025 was 781.00M, edged down 0.1% below 2024.
AstraZeneca Shares Outstanding 2024: 781.50M
AstraZeneca diluted shares outstanding in 2024 was 781.50M, edged up 0.1% from 2023.
AstraZeneca Shares Outstanding 2023: 781.00M
AstraZeneca diluted shares outstanding in 2023 was 781.00M, edged up 0.1% from 2022.
AstraZeneca Shares Outstanding 2022: 780.00M
AstraZeneca diluted shares outstanding in 2022 was 780.00M, grew 9.3% from 2021.
AstraZeneca Shares Outstanding 2021: 713.50M
AstraZeneca diluted shares outstanding in 2021 was 713.50M.
See more financial history for AstraZeneca (AZN).
Sector peers — Shares Outstanding
Companies in the same sector as AstraZeneca, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | 377.00M | Healthcare |
Frequently asked questions
What is AstraZeneca's diluted shares outstanding?
- Latest reported diluted shares outstanding for AstraZeneca (AZN) is 781.00M (period ending December 31, 2025).
How has AstraZeneca diluted shares outstanding changed year-over-year?
- AstraZeneca (AZN) diluted shares outstanding changed -0.1% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca diluted shares outstanding?
- AstraZeneca (AZN) diluted shares outstanding compound annual growth rate is +3.5% over the most recent 5 years available.
When did AstraZeneca diluted shares outstanding hit its highest annual value?
- AstraZeneca diluted shares outstanding reached its highest annual value of 888.00M in 1999.
What was AstraZeneca diluted shares outstanding in 2024?
- AstraZeneca (AZN) diluted shares outstanding in 2024 was 781.50M.
What was AstraZeneca diluted shares outstanding in 2025?
- AstraZeneca (AZN) diluted shares outstanding in 2025 was 781.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.